REQUEST A DEMO
Total
USD $0.00
Search more companies

Hemomont D.O.O. (Montenegro)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hemomont D.O.O. Podgorica Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Hemomont D.O.O. is an enterprise in Montenegro, with the main office in Podgorica. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Hemomont D.O.O. was incorporated on April 02, 2026. Hemomont D.O.O. currently employs 160 (2019) people. From the latest financial highlights, Hemomont D.O.O. reported a net sales revenue drop of 6.78% in 2024. A growth of 12.63% was recorded in its total assets. In 2024, Hemomont D.O.O.’s net profit margin decreased by 2.95%.

Headquarters
Ul. 8. Marta 55a
Podgorica; Podgorica; Postal Code: 81000

Contact Details: Purchase the Hemomont D.O.O. report to view the information.

Website: http://www.hemofarm.com

Basic Information
Total Employees:
Purchase the Hemomont D.O.O. report to view the information.
Financial Auditors:
Purchase the Hemomont D.O.O. report to view the information.
Incorporation Date:
April 02, 2026
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
71.02%
Purchase this report to view the information.
19.35%
Purchase this report to view the information.
9.63%
Company Performance
Financial values in the chart are available after Hemomont D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-6.78%
Total Operating Revenue
-6.42%
Operating Profit
-60.83%
EBITDA
-37.97%
Net Profit/Loss for the Period
-65.56%
Total Assets
12.63%
Total Equity
3.06%
Operating Profit Margin
-3.18%
Net Profit Margin
-2.95%
Return on Equity (ROE)
-5.92%
Debt / Equity
0%
Quick Ratio
-0.53%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?